Previous 10 | Next 10 |
2023-04-05 20:09:08 ET Simulations Plus, Inc. (SLP) Q2 2023 Earnings Conference Call March 05, 2023 05:00 PM ET Company Participants Brian Siegel - Hayden IR Shawn O'Connor - Chief Executive Officer Will Frederick - Chief Financial Officer Conference Call P...
2023-04-05 16:10:34 ET Simulations Plus press release ( NASDAQ: SLP ): Q2 GAAP EPS of $0.20 beats by $0.02 . Revenue of $15.75M (+6.4% Y/Y) misses by $0.38M . Software revenue increased 7% to $10.5 million, representing 67% of total revenue; Services revenu...
Total revenue of $15.8 million; Diluted Earnings Per Share (EPS) of $0.20; Maintains full-year revenue guidance of $59.3 - $62.0 million (+10-15%) and EPS Guidance of $0.63 - $0.67 Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and s...
More than 150 people from around the world gathered virtually this past February for a panel discussion about how to move the needle on gender equity for women in science. Hosted by Simulations Plus, Inc. (Nasdaq: SLP) as part of their third annual Model-Informed Drug Development (MIDD+...
Drug discovery services partnership with Sino-American Cancer Foundation focuses on the development of actionable hits against the MTHFD2 target Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and ...
Conference call to be on Wednesday, April 5, 2023, at 5 p.m. EDT Simulations Plus, Inc. (Nasdaq: SLP), announced today that it will report financial results for the second quarter of fiscal year 2023, the period ended February 28, 2023, after the close of the financial markets on Wedn...
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that chief executive officer Shawn O’Connor will be presenting at the Sidoti Small-Cap Investor Conference taking place virtuall...
Promising intellectual property resulting from the collaboration with Polish Academy of Sciences will be jointly owned for further development opportunities Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical...
Update includes enhanced PKanalix, Monolix, and Simulx modules Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that its Lixoft division, a leading provider of popu...
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that management will be presenting at Oppenheimer’s 33 rd Annual Healthcare Conference taking place virtually from March 13-...
News, Short Squeeze, Breakout and More Instantly...
Objective to define best practices for the use of novel PBK modeling strategies to support animal-free safety assessment of new chemicals Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulation-enabled performance an...
Total revenue of $18.5 million and diluted earnings per share (EPS) of $0.15 Maintains full-year revenue guidance of $69 to $72 million and updates EPS guidance Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulati...
2024-06-24 16:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...